Formulated phospholipids as non-canonical tlr4 agonists

HIGHLIGHTS

• who: Hong Liang et al. from the Access to Advanced Health Institute (AAHI), Eastlake Ave E, Suite, Seattle, WA, USA Department of Global Health, University of Washington, , th Ave NE, Seattle, WA, USA have published the article: Formulated Phospholipids as Non-Canonical TLR4 Agonists, in the Journal: Pharmaceutics 2022, 14, 2557. of 25/02/2015
• what: The authors examined the individual components of a clinical stage oil-in-water vaccine adjuvant emulsion (referred to a stable emulsion or SE) and their ability to signal through murine and human TLR4s. In this report, the authors show . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.